ABBV AbbVie Inc.
Price Chart
Executive Summary
Two AbbVie executives — SVP and EVP — each sold shares in the open market, totaling approximately $2.57 million in proceeds. Both transactions were open-market sales at prevailing prices, with no indication of forced or non-cash dispositions.
Key Financial Metrics
Actionable Insight
While the dollar amount is small relative to market cap, the coordinated timing and C-suite level of both sellers may signal caution ahead of upcoming earnings or strategic challenges, particularly given AbbVie's reliance on post-Humira revenue transition.
Key Facts
- SVP David Ryan sold 5,230 shares for $1,221,518.80 at $233.56 per share on March 4, 2026
- EVP Perry Siatis sold 5,777 shares for $1,348,987.27 at $233.51 per share on March 2, 2026
- Total open-market sales: $2,570,506.07 across two C-suite executives
- Sales represent 0.00063% of AbbVie's $410.8B market cap
Financial Impact
$2.57 million in open-market sales by two senior executives
Risk Factors
- Perception of insider pessimism despite routine nature of small sales
- Potential for negative market interpretation given lack of offsetting insider buying
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (2 trades, 7d window) | cluster-ABBV-1772834780269 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 31, 2026
9d ago
|
ANALYST-UPGRADE
| $221.54 $220.69 | ▼ −0.39% | ▲ +1.96% | $223.07 (+0.69%) |
|
May 21, 2026
19d ago
|
ANALYST-UPGRADE
| $205.12 $197.69 | ▼ −3.62% | ▼ −4.71% | $223.07 (+8.75%) |
|
May 18, 2026
23d ago
|
Court Ruling
| $209.41 $213.12 | ▲ +1.77% | ▲ +0.15% | $223.07 (+6.52%) |
|
May 1, 2026
5w ago
|
ANALYST-UPGRADE
| $221.54 $220.69 | ▼ −0.39% | ▲ +1.96% | $223.07 (+0.69%) |
|
Apr 29, 2026
5w ago
|
8-K
| $203.89 $206.11 | ▲ +1.09% | ▼ −2.02% | $223.07 (+9.41%) |
|
Apr 21, 2026
7w ago
|
ANALYST-UPGRADE
| $205.12 $197.69 | ▼ −3.62% | ▼ −4.71% | $223.07 (+8.75%) |
|
Apr 3, 2026
9w ago
|
8-K
| $204.99 $204.77 | ▼ −0.11% | ▼ −4.24% | $223.07 (+8.82%) |
|
Mar 23, 2026
11w ago
|
DEFA14A
| $203.51 $215.70 | ▲ +5.99% | ▲ +6.41% | $223.07 (+9.61%) |
|
Mar 2, 2026
14w ago
|
Insider Cluster
| $232.33 $225.58 | ▲ +2.91% | ▲ +1.70% | $223.07 (+3.99%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access